Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Test STudy34

100 years or below
Male
Czxcvx
Learn More

Test STudy67

100 years or below
Male
-For US: Aged 10 to 25 years on the day of inclusion ("10-25 years" means from the day of the 10th birthday to the day before the 26th birthday) For EU: Aged 42 to 89 days or 12 to 18 months or 10 to 50 years on the day of …
Learn More

QA test 19 feb 14

99 years or below
All genders
See protocol section 2 See protocol section 2 See protocol section 3
Learn More

QA test 19 feb 13

99 years or below
All genders
See protocol section 2 See protocol section 2 See protocol section 3
Learn More

QA test 19 feb 15

99 years or below
All genders
See protocol section 2 See protocol section 2 See protocol section 3.
Learn More

QA test 20 feb 1

18 years - 100 years
Male
Phase 4
See protocol section 2 See protocol section 2 See protocol section 3 changed
Learn More
Manual 20 feb

Manual 20 feb

100 years or below
All genders
Did you know your white blood cells can make a big difference? By donating these cells through a process called apheresis, you can help researchers find new life-saving therapeutics and develop medical breakthroughs for various conditions. Sanguine Biosciences is looking to enroll patients in a two-visit research study, conducted at the …
Learn More
Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa

Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa (Baby-COMET)

12 months or below
All genders
Phase 3
Interventional
This is a single group, treatment, Phase 3, open-label study to assess efficacy, safety, pharmacokinetic (PK), pharmacodynamics (PD) of avalglucosidase alfa in treatment-naïve male and female participants with IOPD. Study details include: Study duration: Screening - up to 4 weeks; Primary Analysis Period (PAP) - 52 weeks; Extended Treatment Period …
Check Eligibility

V6.14.1 UAT-Test Trial

100 years or below
All genders
Individuals included in the study will be divided into 2 groups, Stabilization and Control groups, by block randomization method. A standard treatment program (Education + home exercises) will be applied to both groups. In addition to the stabilization group, cervical stabilization exercises will be applied. Individuals will be evaluated with …
Check Eligibility

Test Catchall

100 years or below
All genders
Test Catchall 
Learn More
771 - 780 of 1243